Advertisement: EBCam mid banner
Advertisement: Cambridge Network
Advertisement EY mid banner
Advertisement: Simpsons Creative
ARM Innovation Hub
Mid banner advertisement: BDO
Advertisement: RSM
Barr Ellison Solicitors – commercial property
Advertisement: Wild Knight Vodka
Advertisement: Cambridge Corporate Finance Club
Advertisement: Mogrify
Advertisement: TTP
Advertisement: Innova Systems
RealVNC mid-banner general
RealVNC mid banner careers
23 April, 2015 - 12:16 By Kate Sweeney

Optibrium-ChemAxon alliance gathers momentum

Matthew Segall, CEO of Optibrium

Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, have announced the results of a collaboration to integrate ChemAxon’s Plexus with Optibrium’s StarDrop software suite.

The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design, the companies say.

The StarDrop software platform from Optibrium facilitates multi-parameter optimisation, property prediction and data visualisation to guide the design of high quality compounds for drug discovery projects. 

ChemAxon’s Plexus is a web based collaborative discovery platform which enables scaffold- and reaction-based enumeration of compound libraries. As a result of the collaboration, a seamlessly integrated workflow and user interface is available in StarDrop for the application of Plexus to enumerate compound libraries. These are returned as data sets within StarDrop for detailed analysis, visualisation and selection of compounds with an optimised balance of the properties required for success.

Matthew Segall (above), CEO of Optibrium, will provide an overview of the results of this collaboration at ChemAxon’s European User Group Meeting being held in Budapest, Hungary, May 19-20.

Newsletter Subscription

Stay informed of the latest news and features